now loading...
Wealth Asia Connect Treasury & Capital Markets Europe ESG Forum TechTalk
Treasury & Capital Markets / On The Move
Citi names ECM head for Australia and New Zealand
Rob Jahrling played key role in major equity raising, block trade and M&A deals
The Asset 29 Jun 2022
Rob Jahrling
Rob Jahrling

Citi has appointed managing director Rob Jahrling as sole head of equity capital markets (ECM) for Australia and New Zealand.

Jahrling, co-head of ECM since 2021, has led a number of major equity raisings for clients including Air New Zealand, Sandfire Resources, IGO, National Storage REIT, Shopping Centres Australasia Property Group, and NEXTDC.

He has also played a key role in Citi Australia’s block trade business, which it says has rapidly grown to be the market leader in underwritten ECM block trades by both market share and deal volume, in the last 12 months. Recent transactions include Sumitomo Chemical’s block in Nufarm, Jacobs Engineering’s block in Worley, and Mubadal’s block in Oil Search.

Citi also says his market insights have been valuable in connection with public M&A deals that Citi has advised on, including BHP’s successful US$165 billion unification, the US$16 billion merger between Santos and Oil Search, and the US$10 billion demerger by Woolworths of Endeavour Group.

He will continue to report locally to Alex Cartel, head of Citi's banking, capital markets and advisory function, which encompasses all of the bank’s corporate advisory, capital markets and lending businesses in Australia and New Zealand, and to Douglas Adams and James Fleming, global co-heads of Citi’s ECM business.

Jahrling joined Citi in 2010 as head of equity syndicate, before being appointed co-head of ECM in January 2021.

Conversation
Eric Liu
Eric Liu
portfolio manager, Asian credit
BlackRock
- JOINED THE EVENT -
17th Asia Bond Markets Summit - China Edition
Rebalancing in the transition journey
View Highlights
Conversation
Scott Engle
Scott Engle
group treasurer
AIA
- JOINED THE EVENT -
Webinar
Renminbi in the post-Covid future
View Highlights